Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Desmethyl Amisulpride Hydrobromide

Desmethyl Amisulpride Hydrobromide

148516-54-5

DISCOVER
Dehydro Amlodipine

Dehydro Amlodipine

113994-41-5

DISCOVER
Amlodipine Related Compound A

Amlodipine Related Compound A

2138811-33-1

DISCOVER
Amiodarone EP Impurity F

Amiodarone EP Impurity F

147030-50-0

DISCOVER
Amfepramone HCl

Amfepramone HCl

134-80-5

DISCOVER
Ethyl 4-Aminobenzoate

Ethyl 4-Aminobenzoate

94-09-7

DISCOVER
1-Hydroxyanthraquinone

1-Hydroxyanthraquinone

129-43-1

DISCOVER
Bendamustine HCl

Bendamustine HCl

3543-75-7

DISCOVER
Bexarotene

Bexarotene

153559-49-0

DISCOVER
Bortezomib libre

Bortezomib libre

179324-69-7

DISCOVER
Biochanin A

Biochanin A

491-80-5

DISCOVER
Bumetanide-N-Desbutyl-N-(2-ethylhexyl)

Bumetanide-N-Desbutyl-N-(2-ethylhexyl)

153012-65-8

DISCOVER